New York, New York (PRWEB) February 19, 2013
Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective medical devices, has filed a lawsuit alleging that the Obtryx Transobturator Mid-Urethral Sling System caused injuries and serious complications to an Arizona woman (Case No. 2:13-cv-01527). The suit was filed on January 28th in the U.S. District Court for the Southern District of West Virginia, Charleston Division where it is pending alongside many similar cases as part of the multidistrict litigation entitled In Re: Boston Scientific Corp. Pelvic Repair System Products Liability Litigation (MDL No. 2326). Boston Scientific Corporation has been named as Defendant.
According to the Complaint, the Plaintiff was implanted with the Obtryx Transobturator Mid-Urethral Sling System in February 2006. Thereafter, she suffered numerous complications, allegedly due to the transvaginal mesh. The lawsuit alleges that the mesh was designed defectively and poses a serious risk of injury to women. For instance, the suit alleges, the mesh used in the device is not inert, meaning that it can react with the tissues of the body; this can lead to mesh erosion, where the mesh travels through the tissues of the body and becomes deeply embedded within them. The lawsuit also alleges that the device poses a risk of organ perforation, infection, urinary problems and is overall unfit for use in the female pelvis.
Furthermore, the suit alleges that the Defendants knew about the risks of using the mesh but did not adequately warn the Plaintiff, her doctor or the public. The Plaintiff is suing for physical pain and suffering, emotional distress and economic loss.
Transvaginal mesh implants are intended to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI); pelvic organ prolapse is when the pelvic muscles slide out of place and into the vagina and stress urinary incontinence is the involuntary release of urine. These conditions, which become more common after childbirth, are typically caused by the weakening of the pelvic walls and muscles. Transvaginal mesh is supposed to correct these conditions by providing additional support to the pelvic walls, but the lawsuit alleges that these devices only cause more issues.
The FDA has warned that complications associated with transvaginal mesh are “not rare.” According to a Safety Communication issued by the agency in July 2011, the most common adverse events associated with transvaginal mesh include:
The FDA also stated that there is little evidence indicating that transvaginal mesh is more beneficial than non-mesh methods for treating pelvic organ prolapse. The agency has asked a number of transvaginal mesh manufacturers to conduct postmarket safety studies of the mesh to assess whether or not they cause organ damage and other health issues.
Parker Waichman LLP continues to offer free lawsuit consultations to victims of transvaginal mesh injuries. If you or a loved one experienced complications following POP and stress urinary incontinence (SUI) surgery with mesh, please visit the firm's transvaginal mesh injury page at yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).
Parker Waichman LLP
Gary Falkowitz, Managing Attorney